Bioline Rx Limited
BLRX
$3.83+0.12 (+3.23%)
Aug 18, 2025, 4:00 PM
Financials
| 52Week High | 19.50 | 52Week Low | 1.40 |
| Beta | -0.02 | Current Ratio Annual | 1.76 |
| Current Ratio Quarterly | 2.27 | Gross Margin TTM | 64.90 |
| Market Cap | 53.71M | Net Profit Margin TTM | -15.21 |
| Operating Margin TTM | -80.47 | Price To Book | 0.76 |
| Price To Sales TTM | 0.71 | Quick Ratio Annual | 1.53 |
| Quick Ratio Quarterly | 2.02 | Return On Assets TTM | -6.80 |
| Return On Equity TTM | -23.93 | Return On Investment TTM | -9.28 |
| Revenue Growth Quarterly Yoy | -96.28 | Revenue Growth TTMYoy | 91.68 |
| Revenue Per Share TTM | 0.01 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 33 | 0 | 1 | 1 | 1 | 0 | 2.09M | $450.92K |
| Mar 31, 2025 | 12(-64%) | 12(+%) | 23(+2200%) | 0(-100%) | 0(-100%) | 0 | 9.46K(-100%) | $27.99K(-94%) |
| Jun 30, 2025 | 16(+33%) | 8(-33%) | 4(-83%) | 1(+%) | 2(+%) | 3(+%) | 120.38K(+1173%) | $485.65K(+1635%) |